Tag: Insulin-like growth factor 1 receptor

Progress in the treatment of thyroid-associated ophthalmopathy with teprotumumab

2023，No. 11, Current Issue, Highlights, Review

Authors: Liang Congbi,  Chen Changzheng DOI: 10.3760/cma.j.cn115989-20220526-00249 Published 2023-11-10 Cite as Chin J Exp Ophthalmol, 2023, 41(11): 1140-1144. Abstract                             【Download PDF】 【Read Full Text】 Thyroid-associated ophthalmopathy (TAO) is an autoimmune disease of complex etiology and pathogenesis, which can cause a variety of ocular […]

Advances in the relationship between insulin-like growth factor system and corneal diseases

2020, No. 03, Review

Authors: Zhang Jing,  Zhou Qingjun,  Xie Lixin DOI: 10.3760/cma.j.issn.2095-0160.2020.03.015 Published 2020-03-10 Cite as Chin J Exp Ophthalmol, 2020,38(03): 238-242. Abstract                              [View PDF] [Read Full Text] Recently, an increasing number of studies on the insulin-like growth factor (IGF) system have been conducted.In addition to its well-known regulation […]

Current research of hyaluronic acid and thyroid-associated ophthalmopathy

2016, No. 11, Review

Authors：Chen Xiaoling,  He Weimin DOI: 10.3760/cma.j.issn.2095-0160.2016.11.018 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1047-1050. Abstract                               [Download PDF] [Read Full Text] Thyroid-associated ophthalmopathy (TAO) is a common orbital disease in the adults, and glycosaminoglycan deposits in the periorbital connective tissue is one of important pathological features.Hyaluronic acid is […]